News
November 12, 2021

Regenstrief and IU Fairbanks researcher honored with statewide healthcare award

Regenstrief research scientist Nir Menachemi, PhD, MPH, received the Indiana Healthcare Executives Network (iHEN) service excellence award for his work responding to the COVID-19 pandemic. Dr. Menachemi is also the Fairbanks Endowed Chair, professor and health policy and management department chair at the Indiana University Richard M. Fairbanks School of Public Health. 

The iHEN service excellence award honors an individual who has demonstrated dedication in providing exceptional service to citizens and healthcare workers in Indiana. Recognized for his work on the Indiana prevalence study and other pandemic response activities, Dr. Menachemi and his team partnered with state and local officials and hospital executives to support real-time decisions made about the pandemic. In addition, the award acknowledged his leadership in training health administration and public health students in Indiana.

“This award recognizes the hard work and sacrifices of our faculty and staff in response to the pandemic,” said Dr. Menachemi. “I am fortunate to work with a great set of colleagues both inside the Fairbanks School and within partner organizations around the state. From COVID-19 research and practice, to assuring the success of our students, each member of our faculty and staff has made an indelible mark on Indiana’s health in the last 18 months.”

  • Dr. Menachemi

Related News

(From left to right) Dr. Brian Dixon, Dr. Sanji De Sylva and Isaac Vetter. Photo credit: Svetlana Efimova

Regenstrief experts advance global dialogue on digital health and interoperability at forum in Dubai

Regenstrief informaticians joined global leaders who shared their expertise at the 8th ZIMAM Digital Health Forum November 5-6, in

Regenstrief researchers join national stage to advance aging and gerontology research

Regenstrief Institute research scientists joined leading experts from across the nation at the Gerontological Society of America (GSA) 2025

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time